< Back to all Breaking News
EQRX
1/18/2022 19:01pm
EQRx says sugemalimab shows statistically significant OS benefit 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
